Evidence map›Paper›PMID 23350008›Full record

ArticlePLoS neglected tropical diseases2013

Naphthoquinone derivatives exert their antitrypanosomal activity via a multi-target mechanism.

Simone Pieretti, Jurgen R Haanstra, Muriel Mazet, Remo Perozzo, Christian Bergamini, Federica Prati, Romana Fato, Giorgio Lenaz, Giovanni Capranico, Reto Brun and 5 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 105 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Cytotoxicity, hemolysis andToxicology reports · 2016
    Article
  9. Review
  10. Article
  11. Antiparasitic chemotherapy: from genomes to mechanisms.Annual review of pharmacology and toxicology · 2014
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 4 countries.

Simone PierettiDepartment of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
Jurgen R Haanstra
Muriel Mazet
Remo Perozzo
Christian Bergamini
Federica Prati
Romana Fato
Giorgio Lenaz
Giovanni Capranico
Reto Brun
Barbara M Bakker
Paul A M Michels
Leonardo Scapozza
Maria Laura Bolognesi
Andrea Cavalli
University of Bologna · ITUniversity of Geneva · CHde Duve Institute · BEItalian Institute of Technology · ITSwiss Tropical and Public Health Institute · CHUCLouvain · BEUniversity of Groningen · NLUniversity of Lausanne · CHVrije Universiteit Amsterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and methodologyRecently, we reported on a new class of naphthoquinone derivatives showing a promising anti-trypanosomatid profile in cell-based experiments. The lead of this series (B6, 2-phenoxy-1,4-naphthoquinone) showed an ED(50) of 80 nM against Trypanosoma brucei rhodesiense, and a selectivity index of 74 with respect to mammalian cells. A multitarget profile for this compound is easily conceivable, because quinones, as natural products, serve plants as potent defense chemicals with an intrinsic multifunctional mechanism of action. To disclose such a multitarget profile of B6, we exploited a chemical proteomics approach. PRINCIPAL

findingsA functionalized congener of B6 was immobilized on a solid matrix and used to isolate target proteins from Trypanosoma brucei lysates. Mass analysis delivered two enzymes, i.e. glycosomal glycerol kinase and glycosomal glyceraldehyde-3-phosphate dehydrogenase, as potential molecular targets for B6. Both enzymes were recombinantly expressed and purified, and used for chemical validation. Indeed, B6 was able to inhibit both enzymes with IC(50) values in the micromolar range. The multifunctional profile was further characterized in experiments using permeabilized Trypanosoma brucei cells and mitochondrial cell fractions. It turned out that B6 was also able to generate oxygen radicals, a mechanism that may additionally contribute to its observed potent trypanocidal activity. CONCLUSIONS AND SIGNIFICANCE: Overall, B6 showed a multitarget mechanism of action, which provides a molecular explanation of its promising anti-trypanosomatid activity. Furthermore, the forward chemical genetics approach here applied may be viable in the molecular characterization of novel multitarget ligands.

Indexed as

Antiprotozoal AgentsEnzyme InhibitorsGlyceraldehyde-3-Phosphate DehydrogenasesGlycerol KinaseInhibitory Concentration 50Mass SpectrometryNaphthoquinonesProteomeProtozoan ProteinsReactive Oxygen SpeciesTrypanosoma brucei rhodesienseAntiprotozoal AgentsEnzyme InhibitorsGlyceraldehyde-3-Phosphate DehydrogenasesGlycerol KinaseNaphthoquinonesProteomeProtozoan ProteinsReactive Oxygen Species

Identifiers

PMID23350008
PMCPMC3547856
OpenAlexW2035210031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.